,i #aadth ,,congress #ast ,session ,h4 ,r4 #bhje ,,in ,,the ,,house ,,of ,,representatives ,june #ag1 #bjae ,mrs4 ,brooks of ,indiana 7for herself1 ,mr4 ,kennedy1 ,mr4 ,carson of ,indiana1 ,mrs4 ,walorski1 ,mr4 ,whitfield1 and ,mr4 ,messer7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce1 and in addition to the ,committee on the ,judiciary1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to address prescription opioid abuse and heroin use4 #a4 ,short title ,this ,act may be cited as the ,heroin and ,prescription ,opioid ,abuse ,prevention1 ,education1 and ,enforcement ,act of #bjae4 #b4 ,findings ,congress makes the following findings3 7#a7 ,the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hja et seq47 declares that many controlled substances have a useful and legitimate medical purpose and are necessary to maintain the health and general welfare of the people of the ,united ,states4 7#b7 ,health care professionals1 medical experts1 researchers1 and scientists have found pain to be a major national health problem4 7#c7 ,the responsible treatment of pain is a high priority for our ,nation and the needs of individuals with pain must be taken into careful consideration when taking steps to prevent prescription drug misuse and abuse4 7#d7 ,when no longer needed or wanted for legitimate pain management or health treatment1 prescription opioids are susceptible to diversion4 ,prescription opioids also may be abused by individuals who were not prescribed such drugs1 or misused by individuals not taking such drugs as directed4 7#e7 ,approximately #d out of #e new heroin users report that they became addicted to prescription opioids before they used heroin for the first time4 7#f7 ,according to the ,national ,institute on ,drug ,abuse1 heroin attaches to the same brain cell receptors as prescription opioids4 7#g7 ,the low cost and high purity of currently available heroin has contributed to an increase in heroin use across the ,united ,states4 7#h7 ,more people are using heroin1 and are using heroin at a younger age4 ,the ,national ,survey on ,drug ,use and ,health reports that new heroin users numbered #adb1jjj in #bjaj1 and increased to #agh1jjj in #bjaa4 ,in #bjaa1 the average age at first use among heroin abusers between #ab and #di years was #bb4a years4 ,in #bjji1 the average age at first use among heroin abusers between #ab and #di years was #be4e years4 7#i7 ,according to the ,department of ,health and ,human ,services1 heroin use nationwide rose #gi percent between #bjjg and #bjab4 7#aj7 ,deaths from heroin overdose have significantly increased in communities across the ,united ,states4 ,according to the ,centers for ,disease ,control and ,prevention1 the number of deaths involving heroin almost tripled between #bjaj and #bjac4 ,from #bjaj to #bjac1 the number of heroin deaths rose from #c1jcf to #h1beg4 7#aa7 ,the ,edward ,byrne ,memorial ,justice ,assistance ,grant ,program under part ,e of title ,i of the ,omnibus ,crime ,control and ,safe ,streets ,act of #aifh 7#db ,u4,s4,c4 #cgej et seq47 is critical to fighting the prescription opioid abuse and heroin use epidemics1 and should be reauthorized and fully funded4 #c4 ,development of best prescribing practices 7a7 ,inter-,agency task force ,not later than #abj days after the date of enactment of this ,act1 the ,secretary of ,health and ,human ,services 7referred to in this section as the ,secretary71 in cooperation with the ,secretary of ,veterans ,affairs1 the ,secretary of ,defense1 and the ,administrator of the ,drug ,enforcement ,administration1 shall convene a ,pain ,management ,best ,practices ,inter-,agency ,task ,force 7referred to in this section as the task force74 7b7 ,membership ,the task force shall be comprised of-- 7#a7 representatives of-- 7,a7 the ,department of ,health and ,human ,services1 including the ,centers for ,disease ,control and ,prevention2 7,b7 the ,department of ,veterans ,affairs2 7,c7 the ,department of ,defense2 7,d7 the ,drug ,enforcement ,administration2 7,e7 the ,office of ,national ,drug ,control ,policy2 and 7,f7 the ,institute of ,medicine2 and 7#b7 the ,director of the ,national ,institutes of ,health2 7#c7 physicians1 dentists1 and non-physician prescribers2 7#d7 pharmacists2 7#e7 experts in the fields of pain research and addiction research2 7#f7 representatives of-- 7,a7 pain management professional organizations2 7,b7 the mental health treatment community2 7,c7 the addiction treatment community2 and 7,d7 pain advocacy groups2 7#g7 a person in recovery from addiction to medication for chronic pain2 7#h7 a person with chronic pain2 and 7#i7 other stakeholders1 as the ,secretary determines appropriate4 7c7 ,duties ,the task force shall-- 7#a7 not later than #ahj days after the date on which the task force is convened1 develop best practices for pain management and prescription pain medication prescribing practices1 taking into consideration-- 7,a7 existing pain management research2 7,b7 recommendations from relevant conferences2 and 7,c7 ongoing efforts at the ,state and local levels and by medical professional organizations to develop improved pain management strategies2 7#b7 solicit and take into consideration public comment on the best practices developed under paragraph 7#a71 amending such best practices if appropriate2 and 7#c7 develop a strategy for disseminating information about the best practices developed under paragraphs 7#a7 and 7#b7 to prescribers1 pharmacists1 ,state medical boards1 educational institutions that educate prescribers and pharmacists1 and other parties1 as the ,secretary determines appropriate4 7d7 ,limitation ,the task force shall not have rulemaking authority4 7e7 ,report ,not later than #bgj days after the date on which the task force is convened under subsection 7a71 the task force shall submit to ,congress a report that includes-- 7#a7 the strategy for disseminating best practices developed under subsection 7c72 7#b7 the results of a feasibility study on linking best practices developed under paragraphs 7#a7 and 7#b7 of subsection 7c7 to receiving and renewing registrations under section #cjc7;f7 of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hbc7;f772 and 7#c7 recommendations on how to apply such best practices to improve prescribing practices at medical facilities1 including medical facilities of the ,veterans ,health ,administration4 #d4 ,amendments to controlled substance monitoring program ,section #cii,o of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bhj;g-#c7 is amended-- 7#a7 in subsection 7a7-- 7,a7 in paragraph 7#a7-- 7i7 in subparagraph 7,a71 by striking or2 7ii7 in subparagraph 7,b71 by striking the period at the end and inserting 2 or2 and 7iii7 by adding at the end the following3 7,c7 to maintain and operate an existing ,state-controlled substance monitoring program4 2 and 7,b7 in paragraph 7#c71 by inserting by the ,secretary after ,grants awarded2 7#b7 by amending subsection 7b7 to read as follows3 7b7 ,minimum requirements ,the ,secretary shall maintain and1 as appropriate1 supplement or revise 7after publishing proposed additions and revisions in the ,federal ,register and receiving public comments thereon7 minimum requirements for criteria to be used by ,states for purposes of clauses 7ii71 7v71 7vi71 and 7vii7 of subsection 7c77#a77;,a74 2 7#c7 in subsection 7c7-- 7,a7 in paragraph 7#a77;,b7-- 7i7 in the matter preceding clause 7i71 by striking 7a77#a77;,b7 and inserting 7a77#a77;,b7 or 7a77#a77;,c72 7ii7 in clause 7i71 by striking program to be improved and inserting program to be improved or maintained2 7iii7 by redesignating clauses 7iii7 and 7iv7 as clauses 7iv7 and 7v71 respectively2 7iv7 by inserting after clause 7ii7 the following3 7iii7 a plan to apply the latest advances in health information technology in order to incorporate prescription drug monitoring program data directly into the workflow of prescribers and dispensers to ensure timely access to patients' controlled prescription drug history2 2 7v7 in clause 7iv71 as redesignated1 by inserting before the semicolon at the end and at least one health information technology system such as an electronic health records system1 a health information exchange1 or an e-prescribing system2 and 7vi7 in clause 7v71 as redesignated1 by striking public health and inserting public health or public safety2 7,b7 in paragraph 7#c7-- 7i7 by striking ,if a ,state that submits and inserting the following3 7,a7 ,in general ,if a ,state that submits 2 7ii7 by striking the period at the end and inserting and include timelines for full implementation of such interoperability4 ,the ,state shall also describe the manner in which it will achieve interoperability between its monitoring program and health information technology systems1 as allowable under ,state law1 and include timelines for implementation of such interoperability42 and 7iii7 by adding at the end the following3 7,b7 ,monitoring of efforts ,the ,secretary shall monitor ,state efforts to achieve interoperability1 as described in subparagraph 7,a74 2 7,c7 in paragraph 7#e7-- 7i7 by striking implement or improve and inserting establish1 improve1 or maintain2 and 7ii7 by adding at the end the following3 ,the ,secretary shall redistribute any funds that are so returned among the remaining grantees under this section in accordance with the formula described in subsection 7a77#b77;,b742 7#d7 in subsection 7d7-- 7,a7 in the matter preceding paragraph 7#a7-- 7i7 by striking ,in implementing or improving and all that follows through 7a77#a77;,b7 and inserting ,in establishing1 improving1 or maintaining a controlled substance monitoring program under this section1 a ,state shall comply1 or with respect to a ,state that applies for a grant under subparagraph 7,b7 or 7,c7 of subsection 7a77#a72 and 7ii7 by striking public health and inserting public health or public safety2 and 7,b7 by adding at the end the following3 7#e7 ,the ,state shall report to the ,secretary on-- 7,a7 as appropriate1 interoperability with the controlled substance monitoring programs of ,federal departments and agencies2 7,b7 as appropriate1 interoperability with health information technology systems such as electronic health records systems1 health information exchanges1 and e-prescribing systems2 and 7,c7 whether or not the ,state provides automatic1 real-time or daily information about a patient when a practitioner 7or the designee of a practitioner1 where permitted7 requests information about such patient4 2 7#e7 in subsections 7e71 7f77#a71 and 7g71 by striking implementing or improving each place it appears and inserting establishing1 improving1 or maintaining2 7#f7 in subsection 7f7-- 7,a7 in paragraph 7#a7-- 7i7 in subparagraph 7,b71 by striking misuse of a schedule ,,ii1 ,,iii1 or ,,iv substance and inserting misuse of a controlled substance included in schedule ,,ii1 ,,iii1 or ,,iv of section #bjb7;c7 of the ,controlled ,substance ,act2 and 7ii7 in subparagraph 7,d71 by inserting a ,state substance abuse agency1 after a ,state health department12 and 7,b7 by adding at the end the following3 7#c7 ,evaluation and reporting ,subject to subsection 7g71 a ,state receiving a grant under subsection 7a7 shall provide the ,secretary with aggregate data and other information determined by the ,secretary to be necessary to enable the ,secretary-- 7,a7 to evaluate the success of the ,state's program in achieving its purposes2 or 7,b7 to prepare and submit the report to ,congress required by subsection 7l77#b74 7#d7 ,research by other entities ,a department1 program1 or administration receiving nonidentifiable information under paragraph 7#a77;,d7 may make such information available to other entities for research purposes4 2 7#g7 by redesignating subsections 7h7 through 7n7 as subsections 7j7 through 7p71 respectively2 7#h7 in subsections 7c77#a77;,a77iv7 and 7d77#d71 by striking subsection 7h7 each place it appears and inserting subsection 7j72 7#i7 by inserting after subsection 7g7 the following3 7h7 ,education and access to the monitoring system ,a ,state receiving a grant under subsection 7a7 shall take steps to-- 7#a7 facilitate prescriber and dispenser use of the ,state's controlled substance monitoring system2 7#b7 educate prescribers and dispensers on the benefits of the system both to them and society2 and 7#c7 facilitate linkage to the ,state substance abuse agency and substance abuse disorder services4 7i7 ,consultation with ,attorney ,general ,in carrying out this section1 the ,secretary shall consult with the ,attorney ,general of the ,united ,states and other relevant ,federal officials to-- 7#a7 ensure maximum coordination of controlled substance monitoring programs and related activities2 and 7#b7 minimize duplicative efforts and funding4 2 7#aj7 in subsection 7l77#b77;,a71 as redesignated by paragraph 7#g7-- 7,a7 in clause 7ii71 by inserting 2 established or strengthened initiatives to ensure linkages to substance use disorder services2 before or affected patient access2 and 7,b7 in clause 7iii71 by inserting and between controlled substance monitoring programs and health information technology systems1 before 1 including an assessment2 7#aa7 by striking subsection 7m7 7relating to preference71 as redesignated by paragraph 7#g72 7#ab7 by redesignating subsections 7m7 through 7o71 as redesignated by paragraph 7#g71 as subsections 7l7 through 7o71 respectively2 7#ac7 in subsection 7m77#a71 as redesignated by paragraph 7#ab71 by striking establishment1 implementation1 or improvement and inserting establishment1 improvement1 or maintenance2 7#ad7 in subsection 7n7-- 7,a7 in paragraph 7#e7-- 7i7 by striking means the ability and inserting the following3 means-- 7,a7 the ability 2 7ii7 by striking the period at the end and inserting 2 or2 and 7iii7 by adding at the end the following3 7,b7 sharing of ,state controlled substance monitoring program information with a health information technology system such as an electronic health records system1 a health information exchange1 or an e-prescribing system4 2 7,b7 in paragraph 7#g71 by striking pharmacy and inserting pharmacist2 and 7,c7 in paragraph 7#h71 by striking and the ,district of ,columbia and inserting 1 the ,district of ,columbia1 and any commonwealth or territory of the ,united ,states2 and 7#ae7 by amending subsection 7o71 as redesignated by paragraph 7#ab71 to read as follows3 7o7 ,authorization of appropriations ,to carry out this section1 there is authorized to be appropriated #aj1jjj1jjj for each of fiscal years from #bjaf through #bjbj4 4 #e4 ,reauthorization of byrne justice assistance grant program ,section #ejh of title ,i of the ,omnibus ,crime ,control and ,safe ,streets ,act of #aifh 7#db ,u4,s4,c4 #cgeh7 is amended by striking #bjjf through #bjab and inserting #bjaf through #bjbj4 #f4 ,awareness campaigns 7a7 ,in general ,the ,secretary of ,health and ,human ,services shall advance the education and awareness of the public1 providers1 patients1 and other appropriate stakeholders regarding the risk of abuse of prescription opioid drugs if such products are not taken as prescribed4 7b7 ,drug-,free media campaign 7#a7 ,in general ,the ,office of ,national ,drug ,control ,policy1 in coordination with the ,secretary of ,health and ,human ,services and the ,attorney ,general1 shall establish a national drug awareness campaign4 7#b7 ,requirements ,the national drug awareness campaign under paragraph 7#a7 shall-- 7,a7 take into account the association between prescription opioid abuse and heroin use2 7,b7 emphasize the similarities between heroin and prescription opioids and the effects of heroin and prescription opioids on the human body2 and 7,c7 bring greater public awareness to the dangerous effects of fentanyl when mixed with heroin or abused in a similar manner4 7#c7 ,available funds ,funds for the national drug awareness campaign may be derived from amounts appropriated to the ,office of ,national ,drug ,control ,policy and otherwise available for obligation and expenditure4 #g4 ,naloxone demonstration grants 7a7 ,definitions ,in this section-- 7#a7 the term eligible entity means a ,state1 a unit of local government1 or a tribal government2 7#b7 the term first responder includes firefighters1 law enforcement officers1 paramedics1 emergency medical technicians1 and other individuals 7including employees of legally organized and recognized volunteer organizations1 whether compensated or not71 who1 in the course of professional duties1 respond to fire1 medical1 hazardous material1 or other similar emergencies2 and 7#c7 the term opioid overdose reversal drug means a drug that1 when administered1 reverses in whole or part the pharmacological effects of an opioid overdose in the human body4 7b7 ,program authorized ,the ,attorney ,general1 in coordination with the ,secretary of ,health and ,human ,services and the ,director of the ,office of ,national ,drug ,control ,policy1 may make grants to eligible entities to create not more than #h demonstration programs to allow properly trained first responders to prevent prescription opioid and heroin overdose death by administering an opioid overdose reversal drug to an individual who has experienced overdose or who has been determined to have likely experienced overdose4 7c7 ,application 7#a7 ,in general ,to be eligible to receive a grant under this section1 an entity shall submit an application to the ,attorney ,general1 at such time1 in such manner1 and accompanied by such information as the ,attorney ,general shall require1 and-- 7,a7 that meets the criteria for selection under paragraph 7#b72 and 7,b7 that describes-- 7i7 the evidence-based methodology and outcome measures that will be used to evaluate the program funded with a grant under this section1 and specifically explain how such measurements will provide valid measures of the impact of the program2 7ii7 how the program could be broadly replicated if demonstrated to be effective2 7iii7 how the eligible entity will coordinate with their corresponding ,state substance abuse agency to identify protocols and resources that are available to victims and families1 including information on treatment and recovery resources2 and 7iv7 how the demonstration program will continue with ,state1 local1 or private funding after the expiration of the grant4 7#b7 ,criteria for selection ,the ,attorney ,general may award grants to eligible entities that demonstrate an institutional need for technical support and lack existing infrastructure in order to implement and train first responders to carry out a demonstration program under paragraph 7b74 7#c7 ,priority consideration ,in awarding grants under this section1 the ,attorney ,general shall give priority to an eligible entity located in a ,state that provides civil liability protection for first responders administering an opioid overdose reversal drug to counteract opioid overdoses by-- 7,a7 enacting legislation that provides such civil liability protection2 and 7,b7 providing a certification by the attorney general of the ,state that the attorney general has-- 7i7 reviewed any applicable civil liability protection law to determine the applicability of the law with respect to first responders who may administer an opioid overdose reversal drug to individuals reasonably believed to be suffering from opioid overdose2 and 7ii7 concluded that the law described in subparagraph 7,a7 provides adequate civil liability protection applicable to such persons4 7d7 ,use of funds ,an eligible entity shall use a grant received under this section to-- 7#a7 make an opioid overdose reversal drug1 which may include naloxone1 available to be carried and administered by first responders2 7#b7 train and provide resources for first responders1 on carrying and administrating such opioid overdose reversal drug for the prevention of prescription opioid and heroin overdose deaths2 and 7#c7 establish processes1 protocols1 and mechanisms for referral to treatment4 7e7 ,technical support ,the ,attorney ,general shall provide individualized technical support1 as requested1 to grant recipients under this section to assist with implementation of the demonstration program4 7f7 ,grant duration ,a demonstration project grant shall be for a period of #c years4 7g7 ,evaluation ,following the first grant year1 a recipient of a grant awarded under this section shall report to the ,attorney ,general on an annual basis -- 7#a7 the number of first responders equipped with an opioid overdose reversal drug for the prevention of fatal prescription opioid and heroin overdose2 7#b7 the number of prescription opioid and heroin overdoses reversed by first responders2 7#c7 the number of calls for service related to prescription opioid and heroin overdose2 and 7#d7 the extent to which overdose victims and families receive information about treatment services and available data describing treatment admissions4 7h7 ,report to congress ,the ,attorney ,general shall submit an annual report to the appropriate committees of ,congress aggregating the data received from the grant recipients and evaluating the outcomes achieved by the demonstration projects funded under this section4 #h4 ,offset ,it is the sense of ,congress that the amounts expended to carry out this ,act and the amendments made by this ,act should be offset by a corresponding reduction in ,federal non-defense discretionary spending4